Investors
Selventa is funded by industry-leading investors, including Flagship Ventures and Pappas Ventures. As a proud member of these families, Selventa has benefited from their guidance and insight.
| Founded in 2000, Flagship Ventures focuses on creating, financing and building innovative companies. The firm’s strategy is to balance its investments across three principal business sectors: Therapeutics, Life Science Tools and Diagnostics, and BioEnergy/Cleantech. Flagship manages $600 million in early-stage funds and has an active portfolio of more than 40 companies. |
| Founded in 1994, Pappas Ventures only invests in the life sciences – biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Each partnership or long-term collaboration brings promising technologies to commercial application – from concept to commerce. Pappas has helped more than 50 organizations turn breakthrough ideas into market-leading companies. |
